OBJECTIVE: A work function measure specific for persons with prodromal Huntington disease (HD) was created to assist with workplace accommodations. METHODS: A self-report HD Work Function (HDWF) measure was developed from focus group and expert validation. RESULTS: Pilot studies with 238 people with prodromal HD, and 185 companions; and 89 people without prodromal HD, and 70 companions indicate that HDWF has acceptable internal consistency (Cronbach α = 0.77), acceptable interrater reliability (r = 0.58), and acceptable convergent validity with selected items from the Endicott Work Productivity Scale (r = -0.56), Social Adjustment Scale-Self Report (r = -0.29), and Everyday Cognition (r = -0.70). The HDWF can distinguish between people with prodromal HD and people with an HD family history who do not have prodromal HD (P < 0.0001). CONCLUSIONS: The HDWF is a brief self-assessment that may be used to monitor work function.
OBJECTIVE: A work function measure specific for persons with prodromal Huntington disease (HD) was created to assist with workplace accommodations. METHODS: A self-report HD Work Function (HDWF) measure was developed from focus group and expert validation. RESULTS: Pilot studies with 238 people with prodromal HD, and 185 companions; and 89 people without prodromal HD, and 70 companions indicate that HDWF has acceptable internal consistency (Cronbach α = 0.77), acceptable interrater reliability (r = 0.58), and acceptable convergent validity with selected items from the Endicott Work Productivity Scale (r = -0.56), Social Adjustment Scale-Self Report (r = -0.29), and Everyday Cognition (r = -0.70). The HDWF can distinguish between people with prodromal HD and people with an HD family history who do not have prodromal HD (P < 0.0001). CONCLUSIONS: The HDWF is a brief self-assessment that may be used to monitor work function.
Authors: Leigh J Beglinger; Justin J F O'Rourke; Chiachi Wang; Douglas R Langbehn; Kevin Duff; Jane S Paulsen Journal: Psychiatry Res Date: 2010-05-15 Impact factor: 3.222
Authors: Jane S Paulsen; Peggy C Nopoulos; Elizabeth Aylward; Christopher A Ross; Hans Johnson; Vincent A Magnotta; Andrew Juhl; Ronald K Pierson; James Mills; Douglas Langbehn; Martha Nance Journal: Brain Res Bull Date: 2010-04-10 Impact factor: 4.077
Authors: Cheryl Erwin; Janet K Williams; Andrew R Juhl; Michelle Mengeling; James A Mills; Yvonne Bombard; Michael R Hayden; Kimberly Quaid; Ira Shoulson; Sandra Taylor; Jane S Paulsen Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2010-07 Impact factor: 3.568
Authors: Kevin Duff; Jane S Paulsen; Leigh J Beglinger; Douglas R Langbehn; Julie C Stout Journal: Biol Psychiatry Date: 2007-05-03 Impact factor: 13.382
Authors: A Schlote; M Richter; M T Wunderlich; U Poppendick; C Möller; K Schwelm; C W Wallesch Journal: Disabil Rehabil Date: 2009 Impact factor: 3.033
Authors: Flor A Espinoza; Jessica A Turner; Victor M Vergara; Robyn L Miller; Eva Mennigen; Jingyu Liu; Maria B Misiura; Jennifer Ciarochi; Hans J Johnson; Jeffrey D Long; Henry J Bockholt; Vincent A Magnotta; Jane S Paulsen; Vince D Calhoun Journal: Brain Connect Date: 2018-03-08